“Flow with knowledge. Grow with confidence” Educational only. DYODD not financial advice, youtube.com/@zenflow_finance…

Joined November 2025
163 Photos and videos
Pinned Tweet
RAIN INDUSTRIES Everyone knows it as a carbon company. A commodity play. Cyclical. Boring. Move on. But here’s what the market is missing about Rain Industries right now. 🧵
5
15
84
43,977
ZENFLOW WEEK AHEAD. June 15-22 2026. 1. FOMC Decision — June 17 The Fed meets June 16–17. Rate hold is the base case per CME FedWatch, but Powell’s tone on inflation matters. PCE jumped 3.8% in April — any hawkish signal ripples straight into EM flows and the rupee. 2. RIL AGM — June 19 Mukesh Ambani addresses shareholders at the 49th AGM. Market will be listening for one thing: Jio IPO timeline. Any concrete signal on listing plans could re-rate the entire RIL complex. 3. Wipro Buyback Closes — June 17 The ₹15,000 Cr buyback tender window shuts Wednesday. Settlement dynamics and acceptance ratio will drive Wipro price action in the second half of the week. IT sector sentiment follows. 4. Crude Iran-US Geopolitics Brent has been rangebound above $90 on Strait of Hormuz fears. Any escalation or de-escalation in Iran-US negotiations this week is a direct trigger for energy, OMC, and aviation stocks. 5. FPI Flow Watch FPIs have been net sellers every month of 2026 except February — ₹62,800 Cr pulled from equities in the first fortnight of June alone. Whether global risk-on sentiment post-FOMC reverses this matters for mid-cap and smallcap breadth. Five triggers. One week. Stay research-first. — At Zenflow Finance, we track what actually moves markets.
2
90
Everyone called gold “the safest bet of the decade” in 2025. It just broke its 200-day moving average. Here’s what the ETF crowd missed 🧵 Gold hit $4,092. Silver hit $64. The rally felt unstoppable. Then crude oil jumped 30% in 4 months. Suddenly inflation is back. Fed cuts are off the table. Dollar index sits above 100. And gold — the “anti-inflation hedge” — is selling off because of inflation. The irony is brutal. US 2-year yields at 4.13%. Highest since February 2025. Every tick up is a nail in the metals rally. May told the real story: → Gold ETFs: ₹725 crore outflows. First in 13 months. → Silver ETFs: ₹2,133 crore gone. Smart money isn’t panicking. They’re just not buying. “Sell on rise” is the new playbook. Gold eyes $3,800. Silver could test $55. The Strait of Hormuz lit the fuse. But the dollar pulled the trigger. As long as DXY holds 100 , precious metals don’t recover. Simple as that. Fresh money? Wait. Accumulate lower. 15-20% upside still exists — just not today. The 2025 gold trade made legends. The 2026 gold trade will require patience. — At Zenflow Finance, we track what actually moves markets.
3
335
We just dropped a full deep dive on one of India’s most overlooked infrastructure plays. DCI — Dredging Corporation of India. 48 years old. Government-backed. India’s only major dredging company. And yet — persistent net losses, ₹118cr in penalties, an unhedged ECB loan that cost them ₹36cr in forex losses, and interest coverage down to just 1.6x. The fleet average age? 23 years. But here’s what makes this interesting. A brand new dredger arriving October 2026. ₹1,422cr order book. Four major port trusts as promoters feeding nomination orders directly. And a management that believes FY27 is where the story changes. Is this a beaten-down PSU with a real re-rating catalyst — or is the leverage a warning sign the market is choosing to ignore? Watch now- youtu.be/6RvZ1OCXCPQ?si=ZImJ… — At Zenflow Finance, we track what actually moves markets.
1
2
7
1,566
Most investors know the drugs. Few know the stories behind them. Morphine. Penicillin. Statins. Monoclonal Antibodies. Each one didn’t just treat disease — it restructured entire industries, created billion-dollar markets, and rewired how capital flows through healthcare. We made a video tracing how 10 medicines transformed human civilization. And why understanding pharmaceutical history makes you a sharper investor today. Watch now- youtu.be/wPs7SyeaVVY?si=dZ1y… Worth your time! — Zenflow Finance
3
9
1,376
VENUS REMEDIES LTD Everyone ignored this ₹2,000 Cr pharma company. It just posted 127% PAT growth. Zero debt. 20% margins. Trading at 14x forward earnings. Here’s why this could be the most underappreciated specialty injectable play in India right now. 🧵
5
19
86
12,392
Risks that you can’t ignore ⚠️ USFDA/EMA audit risk is real — any 483 could delay advanced market entry ⚠️ API sourcing concentrated in China — dual-sourcing underway but not complete ⚠️ Product concentration in anti-infectives — oncology pivot is early stage Eyes open. Risk-reward still skews heavily positive.
1
3
687
GARP investors, pay attention. Zero debt. Operating leverage. AMR/oncology tailwinds. Global expansion. Patent monetization pipeline. This is what a structural re-rating setup looks like before the street catches on. VENUSREM. Keep this on your radar. — Zenflow Finance | Research-First. Always. Not SEBI registered. Not investment advice. Do your own due diligence.
4
637
UNIHEALTH HOSPITALS. NASHIK JUST GOT ITS REGISTRATION. Most people track hospitals by bed count. The smarter lens is infrastructure depth. UMC Hospitals, Nashik clears that bar. Cath Lab. Robotic Surgery OT. Day Care Dialysis. Dedicated Neurosurgery. Twelve-plus specialties under one roof — in a city that has been chronically underserved for tertiary care. This isn’t a nursing home with ambition. This is a full-stack multi-specialty hospital entering its final commissioning phase — clinical workflows, equipment calibration, staff onboarding. Operations expected in weeks. The Nashik catchment is real. Tier-2 cities in Maharashtra have been bleeding patients to Pune and Mumbai for anything beyond basic care. That’s a long-standing gap. UniHealth is making a calculated bet that the gap closes locally. And this is one piece of a larger play — India AND East Africa. The Group is building geographic diversification into its expansion model at a stage when most hospital chains are still consolidating domestic clusters. Registration secured. Clock is ticking on Day 1 revenues. Watch the ramp-up. — Zenflow Finance
4
14
1,107
THE ECB JUST HIKED. FIRST TIME SINCE 2023. Everyone was screaming rate cuts this year. Dot plots. Pivot narratives. The whole circus. Then the Strait of Hormuz happened. Energy costs climbed. Oil shipments got disrupted. The Iran conflict did what geopolitics always does — it showed up uninvited and broke the consensus trade. 25 bps at the June meeting. Not a hawkish surprise for fun. A central bank telling you that inflation at 3.0% in 2026 — revised UP from 2.6% — doesn’t care about your soft landing thesis. Core inflation sitting at 2.5% through both 2026 and 2027. The ECB didn’t just hike. It repriced the entire forward path. Three years of cuts, pauses, and careful forward guidance — undone by one conflict and one choke point. Markets love certainty. The world keeps delivering complexity. Higher for longer isn’t dead. It just crossed the Atlantic.
1
2
279
SMCGLOBAL is the stock everyone wrote off the moment Zerodha got popular. “Full-service brokers are dead.” “Discount brokers ate their lunch.” “Why pay brokerage when you can pay ₹20 flat?” The obituary was written early. The business didn’t read it. 🧵
1
2
6
1,682
The contrarian case in one line: The market is pricing SMC like a dying full-service broker. The business is actually a diversified financial platform with cycle-trough earnings and a commodity franchise that’s still being discovered. Those two things don’t match.
1
234
We’re watching SMCGLOBAL closely at Zenflow. Not because the next quarter is clean. Because the gap between perception and reality in mid-cap financials is where the real money gets made. Patience. Research. Position sizing. That’s the game. No buy/sell recommendation. — Zenflow Finance 🔍
220